Dr Reddys Laboratories

- Sakshi Post

Dr Reddy's launches cancer drug in the UK

Mar 19, 2024
Chennai, March 19 (IANS) Pharma major Dr Reddy's Laboratories Ltd on Tuesday announced the launch of its cancer drug Versavo (bevacizumab) in the UK.
Dr Reddy's Completes Clinical Trials Of Rituximab For Rheumatoid Arthritis - Sakshi Post

Dr Reddy's Completes Clinical Trials Of Rituximab For Rheumatoid Arthritis

Jan 20, 2023
Hyderabad: Dr.
World Economic Forum recognises Dr. Reddy’s Hyderabad factory as part of its Global Lighthouse Network - Sakshi Post

Dr. Reddy’s Hyderabad Facility Joins WEF's Global Lighthouse Network

Oct 11, 2022
HYDERABAD:  Global pharmaceutical company Dr.
Representational Image - Sakshi Post

Dr Reddy’s Laboratories’ Srikakulam Plant Gets Form 483 from US Health Regulator

Jul 07, 2022
New Delhi: Dr Reddy’s Laboratories Ltd on Thursday informed that the US health regulator has inspected its manufacturing facility located at Srikakulam in Andhra Pradesh and issued Form 483 with two...
- Sakshi Post

DGCI Approves Single Shot Sputnik Light Vaccine For Emergency Use in India

Feb 07, 2022
Dr. Reddy's Laboratories Ltd. today announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation...
- Sakshi Post

Dr Reddy's Labs Shares Increase Over 10 % To Record High

Sep 18, 2020
Dr Reddy's Laboratories' shares rose nearly 10 percent on September 18 to reach their fresh record high of Rs 5,302.85 on BSE.
Anji Reddy's absence not to change DRL's direction: Analysts - Sakshi Post

Anji Reddy's absence not to change DRL's direction: Analysts

Mar 17, 2013
Anji Reddy's absence not to change DRL's direction: Analysts
Back to Top